Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease

por Abboud, Ramzi, Choi, Jaebok, Ruminski, Peter, Schroeder, Mark A., Kim, Sena, Abboud, Camille N., DiPersio, John F.
Publicado 2020

P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA

por Lech-Marańda, Ewa, Szymańska, Agata, Zaucha, Jan, Borthakur, Gautam, Solomon, Scott, Bradley, Terrence, Mouhayar, Elie, Angelosanto, Noemi, Nogai, Hendrik, Brzozka, Krzysztof, Rzymski, Tomasz, Littlewood, Peter, Kus, Kamil, Dudziak, Renata, Glasmacher, Axel, Burris, Howard, Abboud, Camille
Publicado 2023

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

por Hochhaus, Andreas, Gambacorti-Passerini, Carlo, Abboud, Camille, Gjertsen, Bjørn Tore, Brümmendorf, Tim H., Smith, B. Douglas, Ernst, Thomas, Giraldo-Castellano, Pilar, Olsson-Strömberg, Ulla, Saussele, Susanne, Bardy-Bouxin, Nathalie, Viqueira, Andrea, Leip, Eric, Russell-Smith, T. Alexander, Leone, Jocelyn, Rosti, Gianantonio, Watts, Justin, Giles, Francis J.
Publicado 2020

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen

por Ali, Alaa M., Weisel, Daniel, Gao, Feng, Uy, Geoffrey L., Cashen, Amanda F., Jacoby, Meagan A., Wartman, Lukas D., Ghobadi, Armin, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl‐Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Schroeder, Mark A., Westervelt, Peter, DiPersio, John F., Welch, John S.
Publicado 2017

Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy

por Ferraro, Francesca, Gruszczynska, Agata, Ruzinova, Marianna B., Miller, Christopher A., Percival, Mary Elizabeth, Uy, Geoffrey L., Pusic, Iskra, Jacoby, Meagan A., Christopher, Mathew J., Kim, Miriam Y., Westervelt, Peter, Cashen, Amanda F., Schroeder, Mark A., DiPersio, John F., Abboud, Camille N., Wartman, Lukas D., Gao, Feng, Link, Daniel C., Ley, Timothy J., Welch, John S.
Publicado 2022

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

por Uy, Geoffrey L., Duncavage, Eric J., Chang, Gue Su, Jacoby, Meagan A., Miller, Christopher A., Shao, Jin, Heath, Sharon, Elliott, Kevin, Reinick, Teresa, Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Ganel, Liron, Abboud, Camille N., Cashen, Amanda F., DiPersio, John F., Wilson, Richard K, Link, Daniel C., Welch, John S., Ley, Timothy J., Graubert, Timothy A., Westervelt, Peter, Walter, Matthew J.
Publicado 2016

Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia

por Barnell, Erica K., Newcomer, Kenneth F., Skidmore, Zachary L., Krysiak, Kilannin, Anderson, Sydney R., Wartman, Lukas D., Oh, Stephen T., Welch, John S., Stockerl-Goldstein, Keith E., Vij, Ravi, Cashen, Amanda F., Pusic, Iskra, Westervelt, Peter, Abboud, Camille N., Ghobadi, Armin, Uy, Geoffrey L., Schroeder, Mark A., Dipersio, John F., Politi, Mary C., Spencer, David H., Duncavage, Eric J., Ley, Timothy J., Griffith, Malachi, Jacoby, Meagan A., Griffith, Obi L.
Publicado 2021

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

por Desai, Pinkal M., Brown, Janice, Gill, Saar, Solh, Melham M., Akard, Luke P., Hsu, Jack W., Ustun, Celalettin, Andreadis, Charalambos, Frankfurt, Olga, Foran, James M., Lister, John, Schiller, Gary J., Wieduwilt, Matthew J., Pagel, John M., Stiff, Patrick J., Liu, Delong, Khan, Irum, Stock, Wendy, Kambhampati, Suman, Tallman, Martin S., Morris, Lawrence, Edwards, John, Pusic, Iskra, Kantarjian, Hagop M., Mamelok, Richard, Wong, Alicia, Van Syoc, Rodney, Kellerman, Lois, Panuganti, Swapna, Mandalam, Ramkumar, Abboud, Camille N., Ravandi, Farhad
Publicado 2021

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIG...

por Gyurkocza, Boglarka, Seropian, Stuart, Choe, Hannah, Litzow, Mark, Abboud, Camille, Koshy, Nebu, Stiff, Patrick, Tomlinson, Benjamin, Abhyankar, Sunil, Foran, James M, Hari, Parameswaran, Chen, George, Al-Kadhimi, Zaid, Kebriaei, Partow, Sabloff, Mitchell, Orozco, Johnnie, Jamieson, Katarzyna, Silverman, Margarida, Van Besien, Koen, Schuster, Michael, Law, Arjun, Abedin, Sameem, Larkin, Karilyn, Rowley, Scott, Munshi, Pashna, Cook, Rachel, Mayer, Sebastian, Levy, Moshe Yair, Lazarus, Hillard, Sandmaier, Brenda, Reddy, Vijay, Spross, Jennifer, Mcnamara, Kathleen, Haeuber, Elaina, Vusirikala, Madhuri, Nahar, Akash, Pagel, John, Giralt, Sergio, Desai, Avinash, Nath, Rajneesh
Publicado 2023